MARKET

LEXX

LEXX

Lexaria Bioscience Corp
NASDAQ
1.350
+0.030
+2.27%
After Hours: 1.350 0 0.00% 16:05 03/14 EDT
OPEN
1.340
PREV CLOSE
1.320
HIGH
1.400
LOW
1.320
VOLUME
25.48K
TURNOVER
--
52 WEEK HIGH
6.85
52 WEEK LOW
1.150
MARKET CAP
23.70M
P/E (TTM)
-2.7540
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LEXX last week (0303-0307)?
Weekly Report · 4d ago
LEXARIA BIOSCIENCE CORP. 10-Q Quarterly Report (Form 10-Q)
Press release · 03/03 19:44
Weekly Report: what happened at LEXX last week (0224-0228)?
Weekly Report · 03/03 12:00
Lexaria Bioscience Advances Strategy in GLP-1 Drug Sector
TipRanks · 02/27 16:09
Lexaria Bioscience provides GLP-1 strategic update
TipRanks · 02/27 13:55
Lexaria Bioscience Advances GLP-1 Study with New Ethics Approval
TipRanks · 02/24 15:32
Lexaria receives HREC approval for DehydraTECH-tirzepatide GLP-1 study arm
TipRanks · 02/24 14:15
Weekly Report: what happened at LEXX last week (0217-0221)?
Weekly Report · 02/24 12:00
More
About LEXX
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its primary research programs are the investigation of optimal formulations of DehydraTECH-enhanced glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drugs as well as the investigation of cannabidiol (CBD) for the reduction of hypertension leading to a cleared IND application by the United States Food and Drug Administration. It operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 46 patents granted and many patents pending worldwide.

Webull offers Lexaria Bioscience Corp stock information, including NASDAQ: LEXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEXX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEXX stock methods without spending real money on the virtual paper trading platform.